# Nivolumab

## Opdivo inj 120mg/12mL

##### 臨採

| TAH Drug Code      | [IOPDI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IOPDI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Unresectable or metastatic melanoma 2. Adjuvant treatment of melanoma 3. Neoadjuvant treatment for resectable non-small cell lung cancer 4. Non-small cell lung cancer 5. Malignant pleural mesothelioma 6. Renal cell carcinoma 7. Squamous cell carcinoma of the head and neck 8. Classical Hodgkin’s lymphoma 9. Urothelial carcinoma 10. Gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma 11. Hepatocellular carcinoma 12. Metastatic colorectal cancer 13. Esophageal squamous cell carcinoma 14. Adjuvant treatment following resection of esophageal cancer or gastroesophageal junction cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Colorectal cancer, metastatic, microsatellite instability high or mismatch repair deficient/Esophageal or gastroesophageal junction cancer, resected, adjuvant treatment (as a single agent)/ Esophageal cancer, squamous cell carcinoma, unresectable advanced, recurrent, or metastatic/Head and neck cancer, squamous cell carcinoma, recurrent or metastatic (as a single agent; following disease progression on or after platinum-based therapy)/ Hepatocellular carcinoma (previously treated with sorafenib)/ Hodgkin lymphoma, classical (as a single agent)/ Melanoma, stage IIB, stage IIC, stage III, and stage IV, resected, adjuvant therapy (as a single agent)/ Non–small cell lung cancer, metastatic, relapsed or refractory (as a single agent)/ Renal cell carcinoma, advanced, first-line combination therapy/Renal cell carcinoma, advanced, previously treated (as a single agent)/ Urothelial carcinoma, resected, high risk of recurrence, adjuvant therapy (as a single agent)/ Urothelial carcinoma, locally advanced or metastatic, previously treated (as a single agent; with disease progression during or following a platinum-containing chemotherapy or with disease progression within 12 months of neoadjuvant or adjuvant treatment with a platinum-containing chemotherapy ) : Single-agent therapy: IV: 240 mg once every 2 weeks or 480 mg once every 4 weeks; continue until disease progression or unacceptable toxicity. Combination therapy: IV: 3 mg/kg once every 3 weeks (in combination with ipilimumab) for 4 combination doses, followed by nivolumab (as a single agent) 240 mg once every 2 weeks or 480 mg once every 4 weeks; continue until disease progression or unacceptable toxicity. Esophageal cancer, adenocarcinoma, advanced or metastatic/Gastric cancer or gastroesophageal junction cancer, advanced or metastatic: IV: 240 mg once every 2 weeks or 360 mg once every 3 weeks, in combination with fluoropyrimidine- and platinum-containing chemotherapy; continue until disease progression, unacceptable toxicity, or up to 2 years. Malignant pleural mesothelioma, unresectable (first-line treatment)/ Non–small cell lung cancer, metastatic or recurrent: IV: 360 mg once every 3 weeks (in combination with ipilimumab); continue until disease progression, unacceptable toxicity, or for up to 2 years in patients without disease progression. Melanoma, metastatic with brain metastases (off-label use): IV: 1 mg/kg once every 3 weeks (in combination with ipilimumab) for 4 combination doses, followed by 3 mg/kg once every 2 weeks (nivolumab monotherapy); total duration of nivolumab therapy is up to 24 months, or until disease progression or unacceptable toxicity. Melanoma, unresectable or metastatic: Single-agent therapy: IV: 240 mg once every 2 weeks or 480 mg once every 4 weeks; continue until disease progression or unacceptable toxicity. Combination therapy: IV: 1 mg/kg once every 3 weeks (in combination with ipilimumab) for a maximum of 4 combination doses or until unacceptable toxicity (whichever occurs earlier), followed by nivolumab (as a single agent) 240 mg once every 2 weeks or 480 mg once every 4 weeks; continue until disease progression or unacceptable toxicity. Non–small cell lung cancer, resectable, neoadjuvant therapy/Non–small cell lung cancer, resectable, neoadjuvant and adjuvant therapy/Non–small cell lung cancer, metastatic, with PD-L1 expression (?1%): IV: 360 mg once every 3 weeks (in combination with histology-based platinum-doublet chemotherapy) for 3 cycles. Urothelial carcinoma, unresectable or metastatic: First-line combination therapy: IV: 360 mg once every 3 weeks (in combination with cisplatin and gemcitabine) for up to 6 cycles, followed by nivolumab (as a single agent) 240 mg once every 2 weeks or 480 mg once every 4 weeks; continue until disease progression, unacceptable toxicity or for up to 2 years from first dose in patients without disease progression. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Specific contraindications have not been determined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | >10%: Cardiovascular: Edema (12%), hypertension (11%) Dermatologic: Pruritus (13% to 30%), skin rash (21% to 40%), vitiligo (10% to 11%) Endocrine & metabolic: Hypercalcemia (12%), hyperglycemia (46%), hyperkalemia (12% to 32%), hyperthyroidism (6% to 11%), hypocalcemia (10% to 17%), hypokalemia (12%), hypomagnesemia (16%), hyponatremia (16% to 22%), hypothyroidism (11% to 14%), increased serum albumin (21%), weight loss (7% to 13%) Gastrointestinal: Abdominal pain (17% to 21%), decreased appetite (13% to 22%), diarrhea (23% to 37%; grades 3/4: ?5%), increased serum amylase (17% to 34%), increased serum lipase (22% to 33%), nausea (14% to 30%; grades 3/4: <1%), vomiting (20%; grades 3/4: ?1%) Hematologic & oncologic: Anemia (19% to 41%; grades 3/4: ?3%), leukopenia (14%), lymphocytopenia (27% to 44%; grades 3/4: ?17%), neutropenia (10% to 24%; grades 3/4: ?2%) Hepatic: Hepatitis (2% to 11%), increased serum alanine aminotransferase (20% to 25%), increased serum alkaline phosphatase (21% to 27%), increased serum aspartate aminotransferase (24% to 29%), increased serum bilirubin (13%) Immunologic: Antibody development (11%; neutralizing: <1%) Nervous system: Asthenia (?59%), dizziness (11%), fatigue (?59%), headache (23%) Neuromuscular & skeletal: Arthralgia (10% to 21%), musculoskeletal pain (21% to 42%) Renal: Increased serum creatinine (12% to 19%), kidney impairment (?17%) Respiratory: Cough (?28%), dyspnea (?18%), dyspnea on exertion (?18%), productive cough (?28%), upper respiratory tract infection (17% to 22%) Miscellaneous: Fever (16%) 1% to 10%: Dermatologic: Erythema of skin (10%) Endocrine & metabolic: Adrenocortical insufficiency (1%) Gastrointestinal: Colitis (?6%; severe: 2%), constipation (10%), intestinal perforation (<10%), stomatitis (<10%) Hepatic: Increased gamma-glutamyl transferase (grades 3/4: 4%) Hypersensitivity: Infusion-related reaction (?6%; severe: <1%) Immunologic: Sjogren disease (<10%) Nervous system: Neuritis (<10%), peripheral nerve palsy (peroneal: <10%), peripheral neuropathy (<10%) Neuromuscular & skeletal: Myopathy (<10%), myositis (<10%), polymyositis (<10%), rheumatism (spondyloarthropathy: <10%) Renal: Nephritis (?1%) Respiratory: Pneumonitis (3%) <1%: Cardiovascular: Myocarditis, vasculitis (including acral ischemia) Endocrine & metabolic: Diabetic ketoacidosis, hypoparathyroidism, hypophysitis, thyroiditis, type I diabetes mellitus Gastrointestinal: Duodenitis, gastritis, pancreatitis Hematologic & oncologic: Aplastic anemia, hemolytic anemia, immune thrombocytopenia, lymphadenitis (histiocytic necrotizing lymphadenitis [Kikuchi lymphadenitis]) Immunologic: Organ transplant rejection (corneal graft, solid), sarcoidosis Infection: Systemic inflammatory response syndrome Nervous system: Demyelinating disease, encephalitis (including limbic), exacerbation of myasthenia gravis, Guillain-Barre syndrome, meningitis, myasthenia (myasthenic syndrome), neuropathy (autoimmune), paresis (nerve) Neuromuscular & skeletal: Arthritis, myelitis, polymyalgia rheumatica, rhabdomyolysis Ophthalmic: Iritis, uveitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nivolumab-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

